agilon health, inc. (NYSE:AGL - Get Free Report) rose 12.8% during trading on Wednesday . The company traded as high as $3.46 and last traded at $3.58. Approximately 6,937,005 shares were traded during mid-day trading, an increase of 53% from the average daily volume of 4,530,061 shares. The stock had previously closed at $3.17.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on AGL shares. Macquarie assumed coverage on agilon health in a report on Monday, December 16th. They set a "neutral" rating and a $3.00 price target on the stock. William Blair lowered agilon health from an "outperform" rating to a "market perform" rating in a report on Friday, November 8th. Barclays cut their price target on agilon health from $5.00 to $2.00 and set an "underweight" rating for the company in a research note on Monday, November 11th. Sanford C. Bernstein boosted their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a research note on Wednesday, January 15th. Finally, Citigroup upgraded shares of agilon health from a "sell" rating to a "neutral" rating and raised their target price for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, agilon health presently has a consensus rating of "Hold" and a consensus price target of $3.95.
Check Out Our Latest Stock Analysis on agilon health
agilon health Stock Up 11.5 %
The firm has a 50 day moving average of $3.01 and a two-hundred day moving average of $2.97. The stock has a market capitalization of $1.46 billion, a PE ratio of -3.76 and a beta of 0.67. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.
Insider Activity
In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of the stock in a transaction dated Friday, December 13th. The shares were acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company's stock, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John William Wulf acquired 45,000 shares of the company's stock in a transaction dated Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the purchase, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 77,500 shares of company stock worth $169,600 over the last 90 days. 3.20% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On agilon health
Several hedge funds have recently bought and sold shares of AGL. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of agilon health by 24.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company's stock valued at $1,516,000 after acquiring an additional 157,610 shares during the last quarter. Two Sigma Advisers LP boosted its stake in shares of agilon health by 4,393.5% during the 4th quarter. Two Sigma Advisers LP now owns 480,800 shares of the company's stock worth $914,000 after purchasing an additional 470,100 shares during the last quarter. Two Sigma Investments LP grew its holdings in shares of agilon health by 73.7% during the fourth quarter. Two Sigma Investments LP now owns 857,867 shares of the company's stock worth $1,630,000 after buying an additional 363,855 shares in the last quarter. State of Wyoming grew its holdings in shares of agilon health by 89.3% during the fourth quarter. State of Wyoming now owns 122,504 shares of the company's stock worth $233,000 after buying an additional 57,802 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in shares of agilon health in the fourth quarter valued at approximately $768,000.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.